Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

Published:2015-06 Issue: Volume:4 Page:129-141
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Willis Scooter,De Pradip,Dey Nandini,Long Bradley,Young Brandon,Sparano Joseph A.,Wang Victoria,Davidson Nancy E.,Leyland-Jones Brian R.

Funder

Public Health Service

Breast Cancer Research Foundation

National Cancer Institute

National Institutes of Health

US Department of Defense

Department of Health and Human Services

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference59 articles.

1. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines;Alexopoulou;Breast Cancer Res.,2010

2. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors;Ben-Porath;Nat. Genet.,2008

3. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid);Blum;Cancer Res.,2007

4. Comprehensive molecular portraits of human breast tumours;Cancer;Nature,2012

5. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;Carey;JAMA,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic profiling across breast cancer cell lines and models;Scientific Data;2023-08-04

2. DRAGON: Determining Regulatory Associations using Graphical models on multi-Omic Networks;Nucleic Acids Research;2022-12-19

3. The Prognostic Significance of ALDH-1 and SOX9 Expression in Early Breast Cancer;MIDDLE EAST J CANCER;2022

4. qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer;Breast Cancer Research and Treatment;2021-11-19

5. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway;Annals of Translational Medicine;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3